Ali Rueschhoff

Ali Rueschhoff practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Ali Rueschhoff's NPI, 1497281000, was assigned on May 3, 2017. Ali Rueschhoff graduated from University of Kansas School of Med (KC/Wich/Sal) in 2017. Ali Rueschhoff holds Kansas license BP10059516.

Ali Rueschhoff's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Ali Rueschhoff's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Ali Rueschhoff is also affiliated with Stormont Vail Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Ali Rueschhoff to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ali Rueschhoff practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Ali Rueschhoff's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Ali Rueschhoff's licenses on file in 2 states: Kansas and Texas.

CMS data shows 340 Medicare services from Ali Rueschhoff across 9 procedure codes in 2024, for 167 Medicare patients. Medicare paid $10,268 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 167 Medicare patients who saw Ali Rueschhoff in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ali Rueschhoff's median patient age at 71, with 49% women.

In 2024, Ali Rueschhoff wrote 186 Medicare Part D claims for 48 patients. 64% of them were for generic drugs. CMS names the drug for 114 of them, across 7 drugs with 11 or more claims each, at $8,361 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Ali Rueschhoff for performance year 2024, reported through an alternative payment model (APM). Ali Rueschhoff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ali Rueschhoff as offering telehealth.

Dmand AI links 1 paper to Ali Rueschhoff in 2020. Ali Rueschhoff's most frequent co-authors are Leah A. Cohen, MD, James Davidson Finklea, MD and Raksha Jain, MD.

CMS Open Payments shows 7 general payments to Ali Rueschhoff from 5 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $239.

Ali Rueschhoff graduated from University of Kansas School of Med (KC/Wich/Sal) in 2017.